Pfizer claims its at-home Covid pill STILL beats Omicron and cuts risk of dying by up to 89%  | Daily Mail Online

A study of more than 2,200 at-risk adults by the US-based pharmaceutical giant found its drug, called Paxlovid, reduced the chance of severe outcomes by 89 per cent.